Vol. 15, No. 4, 2021
Problems with Technologies of Genomic Editing and Transgenesis
p. 333 abstract
Genome Editing Technology for the Study and Correction of Neurodegenerative Diseases
p. 339 abstract
Creation and Research of Cell Models of Hereditary Neurodegenerative Diseases Using Directed Genome Editing
p. 353 abstract
Editing the Epigenome in Neurodegenerative Diseases
p. 359 abstract
Using Genome Editing for Alzheimer’s Disease Therapy: from Experiment to Clinic
p. 367 abstract
SLC6A1 and Neuropsychiatric Diseases: The Role of Mutations and Prospects for Treatment with Genome Editing Systems
p. 376 abstract
CRISPR-Cas9 Delivery with the Ribonucleoprotein Complexes Increased EGFP Editing Efficiency
p. 390 abstract
Generation of TNFαR1 and ASIC1a Knockout Human Neural Stem Cells In Vitro by CRISPR/Cas9 System
p. 398 abstract
Toxic Damage to Motor Neurons
p. 410 abstract
Learning Difficulties and Oxidative Stress in Autism Spectrum Disorder: A Review of the Role of Nutritional Interventions
p. 422 abstract
Neurotropic Viruses as a Tool for Neural Circuit-Tracing
p. 435 abstract
Neurochemical and Behavioral Effects of Alpha-Synuclein Oligomers in Three-Month-Old Mice
p. 448 abstract
Intrathecal Infusion of Diosgenin during the Chronic Phase of Spinal Cord Injury Ameliorates Motor Function and Axonal Density
p. 454 abstract
U73122 and m-3M3FBS Regulate the GABAergic Neuron Regeneration via PLCβ in Planarian Dugesia japonica
p. 462 abstract
Genotype–Phenotype Correlation of Novel NF1 Gene Variants Detected by NGS in Patients with Neurofibromatosis Type 1
p. 469 abstract
The Relationship of Antidepressant Therapy with Neuroinflammatory Changes and Inflammatory Response in Major Depressive Disorder
p. 477 abstract
Comparative Assessment of Neurochemical Indices in Patients with Occupational Pathology Caused by Physical and Chemical Factors
p. 482 abstract